Active, Not Recruiting
Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment
NCT05021536
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Barrow Neurological Institute Phoenix, Arizona, United States
- University of Southern California Los Angeles, California, United States
- University of California Irvine Orange, California, United States
- California Pacific Medical Center Research Institute San Francisco, California, United States